Our Foundation
Where We've Been.
A Curve Ball thrown into My 2017 Triathlon Season! “I TRI because I Can” Each year I start the season with the same race, the Mystic YMCA Sprint Triathlon, which consists of a half-mile swim, 15-mile bike and a 5k run. The race was held on Sunday June 4, 2017. This was perfect timing because […]
Game Changer: Metastatic Breast Cancer After being told that I had no evidence of disease, I immediately went back into triathlon training mode. I had made a promise to myself that I was going to do those same six races that I was unable to do the year before. I was determined to get to […]
Swim, Bike, Run…to Find a Cure for Breast Cancer Just Keep Smiling! “Just keep smiling!” has been my motto throughout the last two years of my life. I was 31 years old the first time cancer came into my life. On April 28, 2015 I was diagnosed with stage IIIC Triple Negative, Inflammatory, BRCA2+ Breast […]
How I decided to volunteer with the Terri Brodeur Breast Cancer Foundation My co-worker Michele, who at the time was going through treatment for breast cancer herself, first introduced me to the Terri Brodeur Breast Cancer Foundation (TBBCF) in 2014. One glance at the TBBCF Facebook page, and I was hooked. What really stood out […]
In memoriam Jean (Dutra) Lewis – January 11, 1950-February 7, 2017 TBBCF Walk Participant and Volunteer Obstacles never stopped Jean from living her life to the fullest. She was born with Congenital Aortic Stenosis, which occurs when the heart’s aortic valve narrows. This narrowing prevents the valve from opening fully, which obstructs blood flow from […]
In memoriam Patricia (Pat) Meringolo – December 2, 1942-March 23, 2017 TBBCF Administrative Volunteer and Walk Across SECT Pit Stop Team Lead On March 23, 2017, the Terri Brodeur Breast Cancer Foundation (TBBCF) lost a long-time friend and faithful volunteer, Pat Meringolo, who lost her battle with lung cancer. She was diagnosed in August, […]
Ji Li, PhD Dana-Farber Cancer Institute Basal-like breast tumors comprise a heterogeneous group that accounts for about 15% of all breast cancers. They are highly aggressive and generally fail to respond to targeted therapies. Thus, there is a great need to identify novel vulnerabilities and develop novel therapies for this aggressive breast tumor type. The epithelial-to-mesenchymal […]
Aaron Meyer, PhD Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology Metastatic spread drives the majority of breast cancer mortality and, to do so, requires tumor cells to both disseminate and avoid clearance by the immune system. Inhibiting TAM receptors has shown promising results in models of breast cancer by blocking […]
Heather Parsons, MD, MPH Dana-Farber Cancer Institute This year, breast cancer will claim the lives of more than 500,000 people worldwide. Most of these will be women in whom the disease has spread to the rest of the body, known as metastatic breast cancer. Women living with metastatic breast cancer typically receive ongoing, single-agent treatments that […]
our sponsors
Platinum & Diamond Partners
